Information Provided By: 
Fly News Breaks for January 25, 2018
VAR
Jan 25, 2018 | 07:21 EDT
RBC Capital analyst Brandon Henry raised his price target on Varian Medical to $115 after better than expected Q1 earnings. Henry says the global radiation oncology market has improved, adding that the company can continue to gain market share from Elekta in the near term. The analyst keeps his Sector Perform rating on Varian.
News For VAR From the Last 2 Days
There are no results for your query VAR
